Dr. Karen Bush
Indiana University
The Scientific Advisory Committee provides technical expertise on drug research, development, manufacturing, and distribution, as well as other medical and scientific issues. It consists of fourteen scientific experts from a wide range of relevant disciplines, including:
Members of the Scientific Advisory Committee are selected for three-year terms. To address myriad scientific and technical needs, the Chair has the flexibility to invite scientists to serve as ad hoc members for limited periods of time, or on a project-by-project basis.
Dr. Karen Bush
Indiana University
Dr. Shing Chang
(Formerly) Drugs for Neglected Disease Initiative
Prof. Stewart Cole
Ecole Polytechnique Fédérale de Lausanne
Dr. Michael Dunne
Durata Therapeutics, Inc
Dr. Mark Goldberger
Abbott Laboratories
Dr. Stefan Kaufmann
Max Planck Institute for Infection-Biology
Dr. Dale J. Kempf
Abbott Laboratories
Dr. G. Lynn Marks
GlaxoSmithKline
Prof. Lester A. Mitscher
University of Kansas
Dr. Valerie Mizrahi
Institute of Infectious Disease and Molecular Medicine
Dr. Paul Reider
Princeton University
Dr. Jack Reynolds
Anabios
Dr. Eric Rubin (Chair)
Harvard School of Public Health
Dr. Christine Sizemore
National Institute of Allergy & Infectious Diseases
Dr. Jeffrey A. Staffa
Consilium, LLC